Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000712740 | SCV000339468 | uncertain significance | not provided | 2018-02-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000375878 | SCV000714947 | likely benign | not specified | 2017-11-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics Inc | RCV000712740 | SCV000843262 | likely benign | not provided | 2017-09-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001078715 | SCV001006000 | likely benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000712740 | SCV003809112 | benign | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing |